INIS
patients
95%
skull
90%
humans
66%
genes
66%
radiotherapy
64%
surgery
60%
precision
60%
irradiation
60%
epilepsy
60%
drugs
60%
tumors
58%
computed tomography
45%
therapy
37%
rna
34%
tissues
31%
iodine
30%
energy
30%
protons
30%
capture
30%
blood pressure
30%
validation
30%
maps
30%
lasers
30%
chondrosarcomas
30%
interventions
24%
control
21%
nmr imaging
21%
computerized tomography
20%
concentration
20%
blood-brain barrier
20%
Keyphrases
Chordoma
77%
Randomized Waitlist Controlled Trial
60%
Stereotactic Radiotherapy
60%
Focal Drug-resistant Epilepsy
60%
Stereotactic Irradiation
60%
Skull Base Chordoma
42%
Notochord
35%
Contrast Extravasation
30%
Laser Capture Microdissection
30%
Procedural
30%
Dual-energy Computed Tomography
30%
Skull Base
30%
Proton Therapy
30%
Ectopic Recurrence
30%
Endovascular Stroke Treatment
30%
Blood Pressure
30%
Reference Gene
30%
Open Surgery
26%
Endovascular Treatment
22%
Axial Skeleton
22%
YWHAZ
20%
Phosphoglycerate Kinase 1 (PGK1)
20%
Seizure Frequency
20%
Radiotherapy Treatment
20%
Quantitative PCR
18%
Dual-energy CT
15%
Blood-brain Barrier Disruption
15%
Iodine Concentration
15%
GAPDH
15%
Netherlands
13%
Medicine and Dentistry
Chordoma
100%
Stereotactic Radiotherapy
60%
Drug Resistant Epilepsy
60%
Epileptic Seizure
47%
Base of Skull
38%
Notochord
36%
Skull Base
36%
Recurrent Disease
30%
Proton Therapy
30%
Laser Capture Microdissection
30%
Open Surgery
26%
Real-Time Polymerase Chain Reaction
25%
Gene Expression
18%
Axial Skeleton
18%
Magnetic Resonance Imaging
15%
Neoplasm
15%
Neuromodulation
13%
Drug Therapy
13%
Radiation Therapy
12%
Imaging Technique
8%
Computer Assisted Tomography
8%
Treatment Planning
8%
Flushing
8%
Recurrence Risk
7%
Rare Tumor
7%
Pregnancy
6%
Patient-Reported Outcome
6%
Health Care Cost
6%
Brain Surgery
6%
Patient Population
6%
